Altimmune, Inc. · 15 hours ago
Associate Director, FP&A
Altimmune is a late-clinical stage public biotechnology company advancing transformative therapies for metabolic and liver diseases. The Associate Director, FP&A, will support corporate budgeting, financial reporting, analysis, and forecasting, ensuring accuracy and integration of financial data for senior management decision-making.
BiotechnologyClinical TrialsHealth CareTest and Measurement
Responsibilities
Monthly, quarterly, and annual internal financial reporting
Financial forecasting at all levels
Project analytics
Financial advisor for functional leads
Liaison between external financial reporting, functional leads, and internal reporting
Presentations of financial results to the executive team
Business Case Analysis and Decision Support
Metrics Reporting
Strategic Planning
Additional Responsibilities
Qualification
Required
4+ years of FP&A experience, preferably in a public biopharma company
Approachable financial business partner, with exceptional collaborative communication skills across and between functions
Track record of being a positive energy, excellent team player with an ability to work collaboratively and develop productive relationships with key stakeholders across the organization and externally
Experience building usable, easy-to-understand financial models in drug development companies
Ability to see connections between financials, data, and business drivers, and draw strategic and operational insights from the performance of the business
Advanced financial tools proficiency
Strong oral and written presentation skills – ability to present to executive audiences
Exceptional attention to detail
Strong organizational skills and ability to prioritize work and multitask to meet deadlines
Outstanding time management skills and accountability
BA/BS degree in Finance or Accounting
Preferred
Experience customizing financial reporting in an ERP system is preferred. NetSuite experience is a plus
Master's or CPA preferred
4+ years of progressive experience, preferred experience in a public biopharma company FP&A
Company
Altimmune, Inc.
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases.
Funding
Current Stage
Public CompanyTotal Funding
$66.4MKey Investors
Hercules CapitalBiomedical Advanced Research and Development Authority (BARDA)
2025-05-13Post Ipo Debt· $15M
2019-08-21Grant· $3.7M
2018-09-28Post Ipo Equity· $17M
Recent News
2026-01-06
2026-01-05
2026-01-05
Company data provided by crunchbase